N.M. Code R. § 7.34.4.10
All dried usable cannabis produced by a non-profit producer that is not converted into a concentrated cannabis derived product, and all concentrated cannabis derived products manufactured by a non-profit producer or manufacturer, shall be sampled for testing purposes by the licensed non-profit producer or manufacturer, and those samples shall be tested by an approved laboratory consistent with the requirements of this rule and found to have passed all tests required by this rule, prior to the sale, distribution, or other use of the product. Each batch of dried usable cannabis, other than cannabis that will be converted into a concentrated cannabis derived product, shall be segregated and sampled by the non-profit producer that produced the batch, and the non-profit producer shall ensure that each sample is tested by an approved laboratory in accordance with the testing requirements of this rule and determined to have passed the following individual testing requirements, before dried usable cannabis from that batch is made available for sale or distribution, and before the dried usable cannabis or any substance derived therefrom is incorporated into a cannabis derived product. Each batch of concentrated cannabis derived product shall be segregated and sampled by the manufacturer or non-profit producer that produced the batch, and the manufacturer or non-profit producer (as applicable) shall ensure that each sample is tested by an approved laboratory in accordance with the testing requirements of this rule, and determined by the manufacturer or non-profit producer (as applicable) to have passed the following individual testing requirements, before cannabis derived product from that batch is made available for sale or distribution.
C. Individual testing requirements:
(1) Microbiological test: A non-profit producer shall sample and test dried usable cannabis, and a manufacturer or non-profit producer (as applicable) shall sample and test concentrated cannabis derived products, for microbiological contaminants, using an approved laboratory prior to sale, distribution, or other use. A sample may be deemed to have passed the microbiological test if the sample contains less than each action level set forth in Table 1, Microbiological Testing Requirements, below.
Table 1. Microbiological Testing Requirements Final Product Test Parameter Action Level Test Units Chopped or Powdered Botanicals (Dried Usable Cannabis Not Extracted) Total Aerobic Microbial Count >100000 cfu/g or cfu/mL Total Combined Yeast & Mold Count >1000 cfu/g or cfu/mL Bile-tolerant Gram-negative Bacteria >1000 cfu/g or cfu/mL Absence of Salmonella spp. & E. coli Absent In 10 grams cfu/g or cfu/mL Total Coliforms Count >1000 cfu/g or cfu/mL Powdered Botanical Extracts (Extracted or Processed Cannabis Product i.e. hash, bubble hash, rosin, kief) Total Aerobic Microbial Count >10000 cfu/g or cfu/mL Total Combined Yeast & Mold Count >1000 cfu/g or cfu/mL Bile-tolerant Gram-negative Bacteria >1000 cfu/g or cfu/mL Absence of Salmonella spp. & E. coli Absent In 10 grams cfu/g or cfu/mL Total Coliforms Count >1000 cfu/g or cfu/mL Tinctures (Solutions of Cannabis in Alcohol) Total Aerobic Microbial Count >10000 cfu/g or cfu/mL Total Combined Yeast & Mold Count >1000 cfu/g or cfu/mL Infusions (solutions of cannabis in water) Total Aerobic Microbial Count >100 cfu/g or cfu/mL Total Combined Yeast & Mold Count >10 cfu/g or cfu/mL Decoctions (Solutions of Cannabis derived by boiling in water for at least 15 minutes) Total Aerobic Microbial Count >100 cfu/g or cfu/mL Total Combined Yeast & Mold Count >10 cfu/g or cfu/mL Fluid extracts (An alcoholic liquid extract made by percolation of Cannabis so that 1 mL of the fluidextract represents 1 g of the Cannabis) Total Aerobic Microbial Count >10000 cfu/g or cfu/mL Total Combined Yeast & Mold Count >1000 cfu/g or cfu/mL Nutritional Supplements with Botanicals Total Aerobic Microbial Count >100000 cfu/g or cfu/mL Total Combined Yeast & Mold Count >1000 cfu/g or cfu/mL Absence of Salmonella spp. & E. coli Absent In 10 grams cfu/g or cfu/mL Botanicals to be treated with boiling water before use (Dried Cannabis to which boiling water is added immediately prior to consumption) Total Aerobic Microbial Count >100000 cfu/g or cfu/mL Total Combined Yeast & Mold Count >1000 cfu/g or cfu/mL Absence of E. coli Absent In 10 grams cfu/g or cfu/mL Nutritional products with other highly refined ingredients (Edibles) Total Aerobic Microbial Count >1000 cfu/g or cfu/mL Total Combined Yeast & Mold Count >100 cfu/g or cfu/mL Absence of E. coli Absent In 10 grams cfu/g or cfu/mL Quantitative analysis results shall be rounded off to the first two significant digits. E. coli and Salmonella results shall be reported as Present or Absent.
Table 1. Microbiological Testing Requirements
Final Product
Test Parameter
Action Level
Test Units
Chopped or Powdered Botanicals (Dried Usable Cannabis Not Extracted)
Total Aerobic Microbial Count
>100000
cfu/g or cfu/mL
Total Combined Yeast & Mold Count
>1000
cfu/g or cfu/mL
Bile-tolerant Gram-negative Bacteria
>1000
cfu/g or cfu/mL
Absence of Salmonella spp. & E. coli
Absent
In 10 grams cfu/g or cfu/mL
Total Coliforms Count
>1000
cfu/g or cfu/mL
Powdered Botanical Extracts (Extracted or Processed Cannabis Product i.e. hash, bubble hash, rosin, kief)
Total Aerobic Microbial Count
>10000
cfu/g or cfu/mL
Total Combined Yeast & Mold Count
>1000
cfu/g or cfu/mL
Bile-tolerant Gram-negative Bacteria
>1000
cfu/g or cfu/mL
Absence of Salmonella spp. & E. coli
Absent
In 10 grams cfu/g or cfu/mL
Total Coliforms Count
>1000
cfu/g or cfu/mL
Tinctures (Solutions of Cannabis in Alcohol)
Total Aerobic Microbial Count
>10000
cfu/g or cfu/mL
Total Combined Yeast & Mold Count
>1000
cfu/g or cfu/mL
Infusions (solutions of cannabis in water)
Total Aerobic Microbial Count
>100
cfu/g or cfu/mL
Total Combined Yeast & Mold Count
>10
cfu/g or cfu/mL
Decoctions (Solutions of Cannabis derived by boiling in water for at least 15 minutes)
Total Aerobic Microbial Count
>100
cfu/g or cfu/mL
Total Combined Yeast & Mold Count
>10
cfu/g or cfu/mL
Fluid extracts (An alcoholic liquid extract made by percolation of Cannabis so that 1 mL of the fluidextract represents 1 g of the Cannabis)
Total Aerobic Microbial Count
>10000
cfu/g or cfu/mL
Total Combined Yeast & Mold Count
>1000
cfu/g or cfu/mL
Nutritional Supplements with Botanicals
Total Aerobic Microbial Count
>100000
cfu/g or cfu/mL
Total Combined Yeast & Mold Count
>1000
cfu/g or cfu/mL
Absence of Salmonella spp. & E. coli
Absent
In 10 grams cfu/g or cfu/mL
Botanicals to be treated with boiling water before use (Dried Cannabis to which boiling water is added immediately prior to consumption)
Total Aerobic Microbial Count
>100000
cfu/g or cfu/mL
Total Combined Yeast & Mold Count
>1000
cfu/g or cfu/mL
Absence of E. coli
Absent
In 10 grams cfu/g or cfu/mL
Nutritional products with other highly refined ingredients (Edibles)
Total Aerobic Microbial Count
>1000
cfu/g or cfu/mL
Total Combined Yeast & Mold Count
>100
cfu/g or cfu/mL
Absence of E. coli
Absent
In 10 grams cfu/g or cfu/mL
Quantitative analysis results shall be rounded off to the first two significant digits.
E. coli and Salmonella results shall be reported as Present or Absent.
(2) Mycotoxin test: A non-profit producer shall sample and test dried usable cannabis, and a manufacturer or non-profit producer (as applicable) shall sample and test concentrated cannabis derived products, for mycotoxins, using an approved laboratory prior to sale, distribution, or other use. A sample may be deemed to have passed the mycotoxin test if the total quantity of aflatoxin B1, B2, G1, and G2 and ochratoxin A is collectively less than 20 µg/kg (parts per billion) of the sample. The mycotoxin test shall be conducted in accordance with the testing requirements at Table 2, Mycotoxins Testing Requirements.
Table 2. Mycotoxins Testing Requirements Targeted Mycotoxins Chemical Name Abbreviation CAS Number Method Reporting Level (µg/kg)* Action Level (µg/kg)* Aflatoxins Aflatoxin B1 AFB1 1162-65-8 1.0 Combined concentration of five mycotoxin components: 20 Aflatoxin B2 AFB2 7220-81-7 1.0 Aflatoxin G1 AFG1 1165-39-5 1.0 Aflatoxin G2 AFG2 7241-98-7 1.0 Ochratoxin Ochratoxin A OTA 303-47-9 1.0 Mycotoxins Reporting Requirements for DOH Medical Cannabis Program Use two significant digits when reporting a total mycotoxins result. Non-detects are reported as less than the Method Reporting Level. Example: "Total Mycotoxins < 1 µg/kg" *Micrograms of mycotoxin per kilogram (µg/kg) of sample is equivalent to parts per billion (ppb).
Table 2. Mycotoxins Testing Requirements
Targeted Mycotoxins
Chemical Name
Abbreviation
CAS Number
Method Reporting Level (µg/kg)*
Action Level (µg/kg)*
Aflatoxins
Aflatoxin B1
AFB1
1162-65-8
1.0
Combined concentration of five mycotoxin
components:
20
Aflatoxin B2
AFB2
7220-81-7
1.0
Aflatoxin G1
AFG1
1165-39-5
1.0
Aflatoxin G2
AFG2
7241-98-7
1.0
Ochratoxin
Ochratoxin A
OTA
303-47-9
1.0
Mycotoxins Reporting Requirements for DOH Medical Cannabis Program
Use two significant digits when reporting a total mycotoxins result.
Non-detects are reported as less than the Method Reporting Level. Example: "Total Mycotoxins < 1 µg/kg"
*Micrograms of mycotoxin per kilogram (µg/kg) of sample is equivalent to parts per billion (ppb).
(3) Residual solvent test: A manufacturer or non-profit producer (as applicable) shall sample and test all concentrated cannabis derived products that are manufactured using solvent extraction methods for the presence of solvent residue, using an approved laboratory prior to sale, distribution, or other use. A sample may be deemed to have passed the residual solvent test if the sample contains less than each action level set forth in Table 3, Residual Solvent Testing Requirements. The residual solvent test shall be conducted in accordance with the testing requirements at Table 3.
Table 3. Residual Solvent Testing Requirements Targeted Compounds Common Chemical Name IUPAC Name CAS Number Method Reporting Level (µg/g) or (ppm)* Action Level (µg/g) or (ppm)* Propane propane propane 74-98-6 100 500 Butanes n-butane butane 106-97-8 100 500 isobutane 2-methylpropane 75-28-5 100 500 Pentane n-pentane pentane 109-66-0 100 500 Hexane n-hexane hexane 110-54-3 25 50 Cyclohexane cyclohexane cyclohexane 110-82-7 100 500 Benzene benzene benzene 71-43-2 2.0 2.0 Toluene toluene methylbenzene 108-88-3 100 200 Heptane n-heptane heptane 142-82-5 100 500 Ethylbenzene ethylbenzene ethylbenzene 100-41-4 100 Combined concentration of all four compounds: 400 and Xylenes ortho-xylene 1,2-dimethylbenzene 95-47-6 100 meta-xylene 1,3-dimethylbenzene 108-38-3 200 para-xylene 1,4-dimethylbenzene 106-42-3 Methyl Alcohol methyl alcohol methanol 67-56-1 100 1000 Isopropyl Alcohol isopropanol 2-propanol 67-63-0 200 1000 Methylene Chloride methylene chloride dichloromethane 75-09-2 50 100 Acetone acetone 2-propanone 67-64-1 200 1000 Residual Solvents Reporting Requirements for DOH Medical Cannabis Program Use two significant digits when reporting residual solvent results. Non-detects are reported as less than the Method Reporting Level for each residual solvent. Example: "Benzene < 2.0 µg/g" Note: The isomers meta-xylene and para-xylene cannot be separated chromatographically, so they are reported as a pair. *Micrograms solvent per gram of sample (µg/g) is equivalent to parts per million (ppm).
Table 3. Residual Solvent Testing Requirements
Targeted Compounds
Common Chemical Name
IUPAC Name
CAS Number
Method Reporting Level (µg/g) or (ppm)*
Action Level (µg/g) or (ppm)*
Propane
propane
propane
74-98-6
100
500
Butanes
n-butane
butane
106-97-8
100
500
isobutane
2-methylpropane
75-28-5
100
500
Pentane
n-pentane
pentane
109-66-0
100
500
Hexane
n-hexane
hexane
110-54-3
25
50
Cyclohexane
cyclohexane
cyclohexane
110-82-7
100
500
Benzene
benzene
benzene
71-43-2
2.0
2.0
Toluene
toluene
methylbenzene
108-88-3
100
200
Heptane
n-heptane
heptane
142-82-5
100
500
Ethylbenzene
ethylbenzene
ethylbenzene
100-41-4
100
Combined
concentration of
all four
compounds:
400
and Xylenes
ortho-xylene
1,2-dimethylbenzene
95-47-6
100
meta-xylene
1,3-dimethylbenzene
108-38-3
200
para-xylene
1,4-dimethylbenzene
106-42-3
Methyl Alcohol
methyl alcohol
methanol
67-56-1
100
1000
Isopropyl Alcohol
isopropanol
2-propanol
67-63-0
200
1000
Methylene Chloride
methylene chloride
dichloromethane
75-09-2
50
100
Acetone
acetone
2-propanone
67-64-1
200
1000
Residual Solvents Reporting Requirements for DOH Medical Cannabis Program
Use two significant digits when reporting residual solvent results.
Non-detects are reported as less than the Method Reporting Level for each residual solvent. Example: "Benzene < 2.0 µg/g"
Note: The isomers meta-xylene and para-xylene cannot be separated chromatographically, so they are reported as a pair.
*Micrograms solvent per gram of sample (µg/g) is equivalent to parts per million (ppm).
(4) Potency test: A non-profit producer shall sample and test all dried usable cannabis, and a non-profit producer or manufacturer (as applicable) shall sample and test all concentrated cannabis derived products, for quantity of tetrahydrocannabinol (THC, tetrahydrocannabinolic acid (THCA), cannabidiol (CBD), cannabidiolic acid (CBDA), and also for THC potency and CBD potency, using an approved laboratory prior to sale, distribution, or other use. A non-profit producer may, at the producer’s option, also test for quantity of cannabinol (CBN), cannabigerolic acid (CBGA), cannabigerol (CBG), cannabichromene (CBC), tetrahydrocannabivarin (THCV), and cannabidivarin (CBDV). The potency test shall be conducted in accordance with the testing requirements at Table 4, Potency Testing Requirements.
Table 4. Potency Testing Requirements Cannabinoid Abbreviation CAS Number Reporting Units* Comments Tetrahydrocannabinolic Acid THCA 23978-85-0 mg/g and % (Percent) analysis required by rule Tetrahydrocannabinol THC 1972-08-3 mg/g and % (Percent) analysis required by rule Cannabidiolic Acid CBDA 1244-58-2 mg/g and % (Percent) analysis required by rule Cannabidiol CBD 13956-29-1 mg/g and % (Percent) analysis required by rule THC Potency THC Potency = Percent THCA x 0.877 + Percent THC mg/g and % (Percent) reporting required by the rule and calculation listed CBD Potency CBD Potency = Percent CBDA x 0.877 + Percent CBD mg/g and % (Percent) reporting required by the rule and calculation listed Cannabinol CBN 521-35-7 mg/g and % (Percent) analysis optional, recommended for strain characterization Cannabigerolic Acid CBGA 25555-57-1 mg/g and % (Percent) analysis optional, recommended for strain characterization Cannabigerol CBG 25654-31-3 mg/g and % (Percent) analysis optional, recommended for strain characterization Cannabichromene CBC 20675-51-8 mg/g and % (Percent) analysis optional, recommended for strain characterization Tetrahydrocannabivarin THCV 31262-37-0 mg/g and % (Percent) analysis optional, recommended for strain characterization Cannabidivarin CBDV 24274-48-4 mg/g and % (Percent) analysis optional, recommended for strain characterization *Milligrams per gram (mg/g) of sample; this unit can be also expressed in percent composition of the sample.
Table 4. Potency Testing Requirements
Cannabinoid
Abbreviation
CAS Number
Reporting Units*
Comments
Tetrahydrocannabinolic Acid
THCA
23978-85-0
mg/g and % (Percent)
analysis required by rule
Tetrahydrocannabinol
THC
1972-08-3
mg/g and % (Percent)
analysis required by rule
Cannabidiolic Acid
CBDA
1244-58-2
mg/g and % (Percent)
analysis required by rule
Cannabidiol
CBD
13956-29-1
mg/g and % (Percent)
analysis required by rule
THC Potency
THC Potency = Percent THCA x 0.877 + Percent THC
mg/g and % (Percent)
reporting required by the rule and calculation listed
CBD Potency
CBD Potency = Percent CBDA x 0.877 + Percent CBD
mg/g and % (Percent)
reporting required by the rule and calculation listed
Cannabinol
CBN
521-35-7
mg/g and % (Percent)
analysis optional, recommended for strain characterization
Cannabigerolic Acid
CBGA
25555-57-1
mg/g and % (Percent)
analysis optional, recommended for strain characterization
Cannabigerol
CBG
25654-31-3
mg/g and % (Percent)
analysis optional, recommended for strain characterization
Cannabichromene
CBC
20675-51-8
mg/g and % (Percent)
analysis optional, recommended for strain characterization
Tetrahydrocannabivarin
THCV
31262-37-0
mg/g and % (Percent)
analysis optional, recommended for strain characterization
Cannabidivarin
CBDV
24274-48-4
mg/g and % (Percent)
analysis optional, recommended for strain characterization
*Milligrams per gram (mg/g) of sample; this unit can be also expressed in percent composition of the sample.
A cannabis derived product shall be homogenous in composition with respect to THC potency. A product shall be deemed non-homogenous if ten percent of the infused portion of the product contains more than twenty percent of the total THC contained in the product. In the event that a cannabis derived product does not meet this requirement, the batch shall be wasted in accordance with the provisions of this rule.
(5) Heavy metal test: A non-profit producer shall sample and test all dried usable cannabis, and a non-profit producer or manufacturer (as applicable) shall sample and test all concentrated cannabis derived products, for heavy metals, using an approved laboratory, prior to sale, distribution, or other use. A sample may be deemed to have passed the heavy metals test if the sample contains less than each action level set forth in Table 5, Heavy Metal Testing Requirements. The heavy metals test shall be conducted in accordance with the testing requirements at Table 5.
Table 5. Heavy Metal Testing Requirements Heavy Metals Elemental Symbol IUPAC Name CAS Number Action Level (µg/g) or (ppm)* Method Reporting Level (µg/g) or (ppm)* Arsenic As arsenic 7440-38-2 2.0 0.2 Cadmium Cd cadmium 7440-43-9 0.8 0.2 Lead Pb lead 7439-92-1 1.2 0.2 Mercury Hg mercury 7439-97-6 0.4 0.1 *Micrograms per gram (µg/g) of sample is equivalent to parts per million (ppm).
Table 5. Heavy Metal Testing Requirements
Heavy Metals
Elemental Symbol
IUPAC Name
CAS Number
Action Level (µg/g) or (ppm)*
Method Reporting Level (µg/g) or (ppm)*
Arsenic
As
arsenic
7440-38-2
2.0
0.2
Cadmium
Cd
cadmium
7440-43-9
0.8
0.2
Lead
Pb
lead
7439-92-1
1.2
0.2
Mercury
Hg
mercury
7439-97-6
0.4
0.1
*Micrograms per gram (µg/g) of sample is equivalent to parts per million (ppm).
(6) Pesticide test: A non-profit producer shall sample and test all dried usable cannabis, and a non-profit producer or manufacturer (as applicable) shall sample and test all concentrated cannabis derived products, for pesticide content using an approved laboratory prior to sale, distribution, or other use. A sample may be deemed to have passed the pesticide test if the sample contains less than each action level set forth in Table 6, Pesticide Testing Requirements. The pesticide test shall be conducted in accordance with the testing requirements at Table 6.
Table 6. Pesticide Testing Requirements Targeted Pesticide Common Chemical Name CAS Number Action Level (µg/kg) Method Reporting Level (µg/kg) Abamectin avermectin B1a & avermectin B1b 71751-41-2 500 100 Azoxystrobin azoxystrobin 131860-33-8 200 100 Bifenazate bifenazate 149877-41-8 200 100 Etoxazole etoxazole 153233-91-1 200 100 Imazalil chloramizole 35554-44-0 200 100 Imidacloprid imidacloprid 138261-41-3 400 100 Malathion malathion 121-75-5 200 100 Myclobutanil myclobutanil 88671-89-0 200 100 Permethrins cis-permethrin & trans-permethrin 52645-53-1 200 100 Spinosad spinosyn A & spinosyn D 168316-95-8 200 100 Spiromesifen spiromesifen 283594-90-1 200 100 Spirotetramat spirotetramat 203313-25-1 200 100 Tebuconazole tebuconazole 80443-41-0 400 100 *Micrograms of pesticide per kilogram (µg/kg) of sample is equivalent to parts per billion (ppb).
Table 6. Pesticide Testing Requirements
Targeted Pesticide
Common Chemical Name
CAS Number
Action Level (µg/kg)
Method Reporting Level (µg/kg)
Abamectin
avermectin B1a & avermectin B1b
71751-41-2
500
100
Azoxystrobin
azoxystrobin
131860-33-8
200
100
Bifenazate
bifenazate
149877-41-8
200
100
Etoxazole
etoxazole
153233-91-1
200
100
Imazalil
chloramizole
35554-44-0
200
100
Imidacloprid
imidacloprid
138261-41-3
400
100
Malathion
malathion
121-75-5
200
100
Myclobutanil
myclobutanil
88671-89-0
200
100
Permethrins
cis-permethrin & trans-permethrin
52645-53-1
200
100
Spinosad
spinosyn A & spinosyn D
168316-95-8
200
100
Spiromesifen
spiromesifen
283594-90-1
200
100
Spirotetramat
spirotetramat
203313-25-1
200
100
Tebuconazole
tebuconazole
80443-41-0
400
100
*Micrograms of pesticide per kilogram (µg/kg) of sample is equivalent to parts per billion (ppb).
(8) Random testing of finished cannabis derived products: A non-profit producer or manufacturer that manufactures a cannabis derived product shall establish a schedule for, and shall conduct, random sampling and testing of finished, non-concentrated cannabis derived products, including but not limited to edible cannabis derived products, as follows:
E. Procedures for testing: A licensed non-profit producer and a manufacturer shall ensure that the following testing procedures are followed:
(1) sampling and segregation: a licensed non-profit producer or manufacturer shall remove a sample of no less than the quantities of cannabis or cannabis derived product specified in Table 7, Minimum Test Sample Size, from every batch, and shall transfer the sample to an approved laboratory for testing; the remainder of the batch of dried, usable cannabis or concentrated cannabis-derived product shall be segregated until the licensed non-profit producer receives the results of laboratory testing report and determines whether the batch meets the testing requirements of this rule;
Table 7. Minimum Test Sample Size Targeted Parameter Sample Matrix Analysis Platforms (Instrumentation Used by Lab) Minimum Amount Required for Testing (grams) Cannabis Potency dried usable cannabis HPLC, LCMS 1.0 concentrated cannabis-derived products (CCDP) HPLC, LCMS 1.0 non-concentrated cannabis-derived products (NCCDP) HPLC, LCMS 1.0 Cannabis Moisture Content dried usable cannabis n/a 1.0 Mycotoxins dried usable cannabis, CCDP, or NCCDP HPLC, LCMS, LCMSMS 1.0 Residual Solvents CCDP GC-FID, GC-PID/FID 1.0 CCDP GCMS 0.5 NCCDP GC-FID, GC-PID/FID 5.0 NCCDP GCMS 1.0 Absence of Salmonella spp. & E. coli dried usable cannabis, NCCDP Culture, biochemical, antibody, or nucleic acid- based assays shall be validated microbiological methodology such as FDA, USP, AOAC, or equivalent. 10.0 CCDP 1.0 Total Aerobic Microbial Count dried usable cannabis, CCDP, or NCCDP Direct culture, indirect culture, or non-culture based. Must be validated microbiological methodology such as FDA, USP, AOAC, or equivalent. 10.0 (dried usable cannabis and NCCDP) 1.00 (CCDP) Total Combined Yeast & Mold Count Bile-tolerant Gram-negative Bacteria Total Coliforms Count Pesticides dried usable cannabis HPLC, LCMS, LCMSMS 2.0 Heavy Metals dried usable cannabis, CCDP, NCCDP ICP-MS, FIMS 0.5 Minimum required test size for CCDP = 8 g, Minimum required test sample size for NCCDP = 27.5g, Minimum required test sample size for dried usable cannabis = 25.5 g. Minimum test sample size may change if a validated method is approved by NMDOH MCP
Table 7. Minimum Test Sample Size
Targeted Parameter
Sample Matrix
Analysis Platforms (Instrumentation Used by Lab)
Minimum Amount Required for Testing (grams)
Cannabis Potency
dried usable cannabis
HPLC, LCMS
1.0
concentrated cannabis-derived products (CCDP)
HPLC, LCMS
1.0
non-concentrated cannabis-derived products (NCCDP)
HPLC, LCMS
1.0
Cannabis Moisture Content
dried usable cannabis
n/a
1.0
Mycotoxins
dried usable cannabis, CCDP, or NCCDP
HPLC, LCMS, LCMSMS
1.0
Residual Solvents
CCDP
GC-FID, GC-PID/FID
1.0
CCDP
GCMS
0.5
NCCDP
GC-FID, GC-PID/FID
5.0
NCCDP
GCMS
1.0
Absence of Salmonella spp. & E. coli
dried usable cannabis, NCCDP
Culture, biochemical, antibody, or nucleic acid- based assays shall be validated microbiological methodology such as FDA, USP, AOAC, or equivalent.
10.0
CCDP
1.0
Total Aerobic Microbial Count
dried usable cannabis, CCDP, or NCCDP
Direct culture, indirect culture, or non-culture based. Must be validated microbiological methodology such as FDA, USP, AOAC, or equivalent.
10.0 (dried usable cannabis and NCCDP)
1.00 (CCDP)
Total Combined Yeast & Mold Count
Bile-tolerant Gram-negative Bacteria
Total Coliforms Count
Pesticides
dried usable cannabis
HPLC, LCMS, LCMSMS
2.0
Heavy Metals
dried usable cannabis, CCDP, NCCDP
ICP-MS, FIMS
0.5
Minimum required test size for CCDP = 8 g, Minimum required test sample size for NCCDP = 27.5g, Minimum required test sample size for dried usable cannabis = 25.5 g.
Minimum test sample size may change if a validated method is approved by NMDOH MCP
F. Remediation; subsequent testing: If a sample fails a given test (i.e., if the sample does not measure below the action levels specified in this rule), the non-profit producer or manufacturer (as applicable) shall determine whether remediation is appropriate, and may pursue confirmatory testing at another approved laboratory. In the event that a non-profit producer or manufacturer attempts to remediate cannabis or a cannabis derived product, the batch shall again be sampled and subjected to all of the tests identified in this rule, except those required for heavy metals and pesticides. A batch of usable cannabis that fails a given test and that does not pass the required tests subsequent to remediation conducted in accordance with the terms of this rule, shall be destroyed in accordance with the wastage requirements of this rule. A non-profit producer or manufacturer may remediate cannabis or cannabis derived product in accordance with the following:
[7.34.4.10 NMAC - Rp, 7.34.4.9 NMAC, 6/23/2020]